Lund University research group receives follow-on DKK 1 million grant from Novo Nordisk Foundation for diabetes-related studies
Follicum applies for extended patent for its topical formulation - BioStock
Follicum successfully completes toxicology studies for upcoming FOL-005 Phase IIa clinical trial in patients with hair loss
Follicum files international patent application conferring extended protection for the topical formulation of FOL-005 and other
World TB Day: Iconovo's ICOone platform in the spotlight - BioStock
Follicum receives European patent for the company's peptides for developing first in class diabetes treatments
Is the Age-Old Quest for a Baldness Cure Reaching Its End? | The New Yorker
Follicum receives LUDC post-doc funding for novel diabetes peptide mode of action research
Follicum applies for extended patent for its topical formulation - BioStock
glucotox eng - Follicum
Follicum collaborates with proDERM for the upcoming Phase IIa clinical trial on patients with hair loss
Follicum receives grant of a patent in the U.S. for extended protection of the product candidate FOL-005
Follicum AB reports top-line data from First-in-Man Scalp Study with FOL-005 against hair loss
Clinical progress of Follicum's lead candidate FOL-005 for hair growth presented at the world's largest hair conference
Endpoints News article about Follicum
Follicum featured in the June issue of The New Yorker: “Is the Age-Old Quest for a Baldness Cure Reaching Its End?”
211108 - Information från Follicums extra bolagsstämma
Follicum files patent application for new topical formulation of FOL-005 for hair loss
Om Spotlight Follicum AB will be transferred to Spotlight Stock Market's observation list About Spotlight
182/18 – Last day of trading in Follicum AB's BTU
Follicum (FOLLI) aktie | Videos - Börskollen
Follicum
Follicum takes a step closer to phase III entering 2021 - BioStock
Follicum appoints new CEO and establishes new role as Chief Scientific Officer
Female alopecia – new solutions on the horizon - BioStock
